Burnet Institute
Serge Scrofani is currently serving as Principal at Poplar Advisory and holds a position as a Board Member at FinCap Australia, a private equity group. Additionally, they are a Board Non-Executive Director at the Centre for Eye Research Australia and a Board Member at Burnet Institute. In the past, they held roles at CSL, AusBiotech, Zenyth Therapeutics, Amrad Corporation, The Scripps Research Institute, and The University of Melbourne. Serge Scrofani holds an MBA in Strategy from Melbourne Business School and a PhD in Biological Chemistry from La Trobe University, among other qualifications.
This person is not in any teams
Burnet Institute
Burnet Institute brings together a highly diverse skill base to help solve devastating health problems. Linking medical research with public health action through our international and local field presence, our laboratories, and our mixed development and research cultures drives greater focus on the most relevant global health issues, and a greater impact as a result. Burnet’s expertise in specific infectious diseases of global health significance (especially COVID-19, HIV, malaria, tuberculosis, and viral hepatitis) continues to make an impact on vulnerable communities internationally and in Australia, along with our research and public health programs in women’s and children’s health; alcohol, drugs and harm reduction; sexual and reproductive health; healthy ageing and young people’s health. Burnet Institute is formally accredited as a medical research organisation with the National Health and Medical Research Council (NHMRC), and as a non-government organisation (NGO) with the Australian Department of Foreign Affairs and Trade – Australian Aid. Burnet Institute’s head office is in Melbourne, Australia and we also have offices or representatives in Myanmar, Papua New Guinea and China, as well as supporting projects in other Asia-Pacific countries.